Evidence map›Paper›PMID 39177593›Full record

ArticleJournal of Alzheimer's disease : JAD2024

Impaired Skeletal Development by Disruption of Presenilin-1 in Pigs and Generation of Novel Pig Models for Alzheimer's Disease.

Kyungjun Uh, Kaylynn Monarch, Emily D Reese, Katherine Rodriguez, Junchul Yoon, Lee D Spate, Melissa S Samuel, Sehwon Koh, Paula R Chen, Timothy J Jarome and 3 more

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The curious case of a heterozygous loss-of-functionMolecular neurodegeneration advances · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kyungjun UhFuturistic Animal Resource & Research Center (FARRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), Chungcheongbuk-do, Republic of Korea.
Kaylynn MonarchDivision of Animal Sciences, University of Missouri, Columbia, MO, USA.
Emily D ReeseDivision of Animal Sciences, University of Missouri, Columbia, MO, USA.
Katherine RodriguezDivision of Animal Sciences, University of Missouri, Columbia, MO, USA.
Junchul YoonDivision of Animal Sciences, University of Missouri, Columbia, MO, USA.
Lee D SpateDivision of Animal Sciences, University of Missouri, Columbia, MO, USA.
Melissa S SamuelDivision of Animal Sciences, University of Missouri, Columbia, MO, USA.
Sehwon KohDepartment of Veterinary Medicine and Surgery, University of Missouri, Columbia, MO, USA.
Paula R ChenUnited States Department of Agriculture-Agricultural Research Service, Plant Genetics Research Unit, Columbia, MO, USA.
Timothy J JaromeSchool of Neuroscience, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.
Timothy A AllenCognitive Neuroscience Program, Department of Psychology, Florida International University, Miami, FL, USA.
Randall S PratherDivision of Animal Sciences, University of Missouri, Columbia, MO, USA.
Kiho LeeDivision of Animal Sciences, University of Missouri, Columbia, MO, USA.

Funding

Resource Core for National Swine Resource and Research Center (NSRRC) Years 21-25U42OD011140 · OD · UNIVERSITY OF MISSOURI-COLUMBIA · PI RANDALL S PRATHER · 2012 to 2026
$26.7M
Validating pig models for Alzheimer's diseaseR21AG079292 · NIA · UNIVERSITY OF MISSOURI-COLUMBIA · PI ALLEN, TIMOTHY ALEXANDER, JAROME, TIMOTHY JOSEPH · 2022 to 2022
$447k
NIA NIH HHS R21 AG079292NIH HHS U42 OD011140
6 · The paper itself

Abstract

Background: Presenilin 1 (PSEN1) is one of the genes linked to the prevalence of early onset Alzheimer's disease. In mice, inactivation of Psen1 leads to developmental defects, including vertebral malformation and neural development. However, little is known about the role of PSEN1 during the development in other species. Objective: To investigate the role of PSEN1 in vertebral development and the pathogenic mechanism of neurodegeneration using a pig model. Methods: CRISPR/Cas9 system was used to generate pigs with different mutations flanking exon 9 of PSEN1, including those with a deleted exon 9 (Δexon9). Vertebral malformations in PSEN1 mutant pigs were examined by X-ray, micro-CT and micro-MRI. Neuronal cells from the brains of PSEN1 mutant pigs were analyzed by immunoflourescence, followed by image analysis including morphometric evaluation via image J and 3D reconstruction. Results: Pigs with a PSEN1 null mutation (Δexon9-12) died shortly after birth and had significant axial skeletal defects, whereas pigs carrying at least one Δexon9 allele developed normally and remained healthy. Effects of the null mutation on abnormal skeletal development were also observed in fetuses at day 40 of gestation. Abnormal distribution of astrocytes and microglia in the brain was detected in two PSEN1 mutant pigs examined compared to age-matched control pigs. The founder pigs were bred to establish and age PSEN1ΔE9/+ pigs to study their relevance to clinical Alzheimer's diseases. Conclusions: PSEN1 has a critical role for normal vertebral development and PSEN1 mutant pigs serves as novel resources to study Alzheimer's disease.

Indexed as

Alzheimer DiseaseDisease Models, AnimalPresenilin-1AnimalsAnimals, Genetically ModifiedBone DevelopmentBrainMutationSpineSwinePresenilin-1Alzheimer’s diseaseCRISPR/Cas9PigPresenilin-1

Identifiers

PMID39177593
PMCPMC11492100

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.